Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

OrganiGram Holdings Inc T.OGI

Alternate Symbol(s):  OGI

Organigram Holdings Inc. is focused on producing cannabis for patients and adult-recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. The Company, through its subsidiary, Organigram Inc., is a licensed producer of cannabis, cannabis- derived products and cannabis infused edibles in Canada. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. It specializes in vape and infused pre-roll categories backed by a portfolio of owned brands, including the BOXHOT brand. Its products include pre-milled flower, pre-rolls, weed gummies, shred x vapes, and extracts. It operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. Its subsidiaries also include 10870277 Canada Inc.


TSX:OGI - Post by User

Bullboard Posts
Post by itsnevertoolateon Mar 08, 2018 9:39am
124 Views
Post# 27682057

Mackie raises share price target to $7.00..maintains "buy"

Mackie raises share price target to $7.00..maintains "buy"

 

Globe says Organigram Holdings maintained at "buy"

 

2018-03-08 08:22 ET - In the News

 

The Globe and Mail reports in its Thursday edition that after licensed medical pot producer Organigram Holdings ($4.26) announced that it had received Health Canada approval for the remaining 13 rooms of its 23-room Phase 2 expansion. The Globe's Gillian Livingston writes in the Eye On Equities column that Mackie Research analyst Greg McLeish boosted his share price target to $7 from $6.50. The median share target is $5.75. Mr. McLeish continues to rate the shares "buy." Mr. McLeish says in a note: "The company's Phase 2 expansion includes significant improvements and efficiencies to the cultivation and processing systems. Enhancements include a fully automated irrigation system, automated potting, a fully automated waste destruction system and automated packaging lines. This has resulted in immediate and ongoing cost savings as well as increased yields. Management fully anticipates this will continue to increase with enhanced improvements in cultivation and environmental design in Phase 3 and Phase 4 and through optimization of its pre-vegetation and cloning processes. This will result in higher economies of scale." Canaccord hiked its share target to $5.50 from $5.25 and kept its "speculative buy" rating.

© 2018 Canjex Publishing Ltd. All rights reserved.

 

Bullboard Posts